Marianne Ellen Pavel

Medizinische Fakultät Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology Professur für Endokrinologie

Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors (2020) Grenader T, Pavel ME, Ruszniewski PB, Ćwikła JB, Phan AT, Raderer M, Sedláčková E, et al. Journal article Serio - Side Effect Registry in Immuno-Oncology (2020) Koutzamanidis R, Mentzer D, Knauss S, Broeckelmann PJ, Hassel JC, Ugurel-Becker S, Pavel ME, et al. Conference contribution Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study (2020) Caplin ME, Pavel ME, Phan AT, Cwikla JB, Sedlackova E, Thanh XMT, Wolin EM, Ruszniewski P Journal article Everolimus-induced pneumonitis in neuroendocrine neoplasms: correlation of CT findings and clinical signs (2020) Fehrenbach U, Rodríguez-Laval V, Jann H, Fernández CM, Pavel ME, Denecke T Journal article Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† (2020) Pavel ME, Öberg K, Falconi M, Krenning EP, Sundin A, Perren A, Berruti A Journal article Peritoneal Carcinomatosis in Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: Clinical Impact and Effectiveness of the Available Therapeutic Options (2020) Merola E, Prasad V, Pascher A, Pape UF, Arsenic R, Denecke T, Fehrenbach U, et al. Journal article Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3 (2020) Merola E, Falconi M, Rinke A, Staettner S, Krendl F, Partelli S, Andreasi V, et al. Journal article Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome (2020) Dillon JS, Kulke MH, Hörsch D, Anthony LB, Warner RR, Bergsland E, Welin S, et al. Journal article Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndrome (2019) Hudgens S, Ramage J, Kulke M, Bergsland E, Anthony L, Caplin M, Öberg K, et al. Journal article Tumor growth rate as a validated early radiological biomarker able to reflect treatment-induced changes in neuroendocrine tumors: The GREPONET-2 study (2019) Lamarca A, Ronot M, Moalla S, Crona J, Opalinska M, Lopez CL, Pezzutti D, et al. Journal article